- Home
- POOL vs SXTC Comparison
POOL vs SXTC Comparison
Compare POOL & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POOL
- SXTC
- Stock Information
- Founded
- POOL 1993
- SXTC 2005
- Country
- POOL United States
- SXTC China
- Employees
- POOL N/A
- SXTC N/A
- Industry
- POOL Industrial Specialties
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- POOL Consumer Discretionary
- SXTC Health Care
- Exchange
- POOL Nasdaq
- SXTC Nasdaq
- Market Cap
- POOL N/A
- SXTC 34.4M
- IPO Year
- POOL 1995
- SXTC 2019
- Fundamental
- Price
- POOL $302.02
- SXTC $1.83
- Analyst Decision
- POOL Buy
- SXTC
- Analyst Count
- POOL 8
- SXTC 0
- Target Price
- POOL $347.63
- SXTC N/A
- AVG Volume (30 Days)
- POOL 759.0K
- SXTC 658.2K
- Earning Date
- POOL 07-24-2025
- SXTC 01-01-0001
- Dividend Yield
- POOL 1.66%
- SXTC N/A
- EPS Growth
- POOL N/A
- SXTC N/A
- EPS
- POOL 10.70
- SXTC 20.77
- Revenue
- POOL $5,261,669,000.00
- SXTC $1,818,404.00
- Revenue This Year
- POOL $2.26
- SXTC N/A
- Revenue Next Year
- POOL $4.25
- SXTC N/A
- P/E Ratio
- POOL $28.22
- SXTC $0.09
- Revenue Growth
- POOL N/A
- SXTC 6.78
- 52 Week Low
- POOL $282.22
- SXTC $0.95
- 52 Week High
- POOL $395.60
- SXTC $11.92
- Technical
- Relative Strength Index (RSI)
- POOL 53.22
- SXTC 52.64
- Support Level
- POOL $286.00
- SXTC $1.68
- Resistance Level
- POOL $312.14
- SXTC $1.92
- Average True Range (ATR)
- POOL 8.06
- SXTC 0.13
- MACD
- POOL 1.49
- SXTC 0.01
- Stochastic Oscillator
- POOL 66.18
- SXTC 67.02
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.